Search

everythinglearnresearchcommunity

for

Search:↓

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Melatonin helps hair growth in women with hair loss.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Minoxidil needs activation to work, and minoxidil sulfate helps with hair growth and blood pressure.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Growth factors and microneedle therapy increase hair density in women with hair loss.

Low prolactin in young women may increase heart and metabolism risks.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.